Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

× No keyword cloud information.

12 in total

1. Breast Cancer OncoGuia.

Authors: Paula Manchon; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal: Clin Transl Oncol Date: 2010-02 Impact factor: 3.405

2. Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - a Prospective Clinical Study.

Authors: Akshay Anand; Kul R Singh; Surender Kumar; Nuzhat Husain; Jitendra K Kushwaha; Abhinav A Sonkar
Journal: Breast Care (Basel) Date: 2017-06-16 Impact factor: 2.860

Review 3. Exemestane: a review of its use in postmenopausal women with breast cancer.

Authors: Emma D Deeks; Lesley J Scott
Journal: Drugs Date: 2009 Impact factor: 9.546

4. Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer.

Authors: Merel L Kimman; Monique Mf Bloebaum; Carmen D Dirksen; Ruud Ma Houben; Philippe Lambin; Liesbeth J Boersma
Journal: BMC Cancer Date: 2010-04-30 Impact factor: 4.430

5. Disease-free survival and prognostic significance of metastatic lymph node ratio in T1-T2 N positive breast cancer patients. A population registry-based study in a European country.

Authors: David Martinez-Ramos; Javier Escrig-Sos; Miguel Alcalde-Sanchez; Ana Torrella-Ramos; Jose Luis Salvador-Sanchis
Journal: World J Surg Date: 2009-08 Impact factor: 3.352

Review 6. Letrozole: a review of its use in the treatment of postmenopausal women with hormone-responsive early breast cancer.

Authors: Gillian M Keating
Journal: Drugs Date: 2009-08-20 Impact factor: 9.546

7. Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria.

Authors: Jamal Zekri; Meteb Al-Foheidi; Maaz Alata; Reem Zabani; Ayman Rasmy
Journal: Breast Care (Basel) Date: 2020-03-10 Impact factor: 2.860

8. Options for early breast cancer follow-up in primary and secondary care - a systematic review.

Authors: Frances Taggart; Peter Donnelly; Janet Dunn
Journal: BMC Cancer Date: 2012-06-13 Impact factor: 4.430

9. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

Authors: Volkmar Müller; Christoph Thomssen; Marcus Schmidt; Manfred Glados; Christian Jackisch; Volker Heilmann; Axel Hinke; Antje Lehnert; Henryk Borowicz; Volker Möbus
Journal: BMC Cancer Date: 2010-08-16 Impact factor: 4.430

10. SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?

Authors: Maria Tengström; Arto Mannermaa; Veli-Matti Kosma; Ari Hirvonen; Vesa Kataja
Journal: BMC Cancer Date: 2012-06-18 Impact factor: 4.430